血栓模块素可以缓解脂肪性肝细胞癌的进展

相关实验视频

Updated: May 12, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

17.1K

Megumi Yamaguchi1, Hirotaka Tashiro1,2, Shintaro Kuroda3

  • 1Department of Clinical Research, Kure Medical Center and Chugoku Cancer Center, National Hospital Organization, Hiroshima, Japan.

Journal of hepatocellular carcinoma
|March 3, 2026
PubMed
概括

代谢功能障碍和肝肥胖症通过降低血栓模块素 (TM) 的调节促进肝癌转移. 再组合TM (rTM) 通过抑制高流动性组盒1 (HMGB-1) 活动来抑制这种进展.

关键词:
肝细胞癌是肝细胞癌.高运动性组第1框缺血 - 再输血 缺血 - 再输血牛脂性肝脏是什么 牛脂性肝血栓模块素是一种血栓模块素.

更多相关视频

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma07:59

Portal Vein Injection of Colorectal Cancer Organoids to Study the Liver Metastasis Stroma

Published on: September 3, 2021

7.2K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

6.3K

相关概念视频

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...